Haemodialysis-associated amyloidosis

Jump to navigation Jump to search
Haemodialysis-associated amyloidosis
ICD-10 E85.3
ICD-9 277.3
eMedicine med/3384 

WikiDoc Resources for Haemodialysis-associated amyloidosis

Articles

Most recent articles on Haemodialysis-associated amyloidosis

Most cited articles on Haemodialysis-associated amyloidosis

Review articles on Haemodialysis-associated amyloidosis

Articles on Haemodialysis-associated amyloidosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Haemodialysis-associated amyloidosis

Images of Haemodialysis-associated amyloidosis

Photos of Haemodialysis-associated amyloidosis

Podcasts & MP3s on Haemodialysis-associated amyloidosis

Videos on Haemodialysis-associated amyloidosis

Evidence Based Medicine

Cochrane Collaboration on Haemodialysis-associated amyloidosis

Bandolier on Haemodialysis-associated amyloidosis

TRIP on Haemodialysis-associated amyloidosis

Clinical Trials

Ongoing Trials on Haemodialysis-associated amyloidosis at Clinical Trials.gov

Trial results on Haemodialysis-associated amyloidosis

Clinical Trials on Haemodialysis-associated amyloidosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Haemodialysis-associated amyloidosis

NICE Guidance on Haemodialysis-associated amyloidosis

NHS PRODIGY Guidance

FDA on Haemodialysis-associated amyloidosis

CDC on Haemodialysis-associated amyloidosis

Books

Books on Haemodialysis-associated amyloidosis

News

Haemodialysis-associated amyloidosis in the news

Be alerted to news on Haemodialysis-associated amyloidosis

News trends on Haemodialysis-associated amyloidosis

Commentary

Blogs on Haemodialysis-associated amyloidosis

Definitions

Definitions of Haemodialysis-associated amyloidosis

Patient Resources / Community

Patient resources on Haemodialysis-associated amyloidosis

Discussion groups on Haemodialysis-associated amyloidosis

Patient Handouts on Haemodialysis-associated amyloidosis

Directions to Hospitals Treating Haemodialysis-associated amyloidosis

Risk calculators and risk factors for Haemodialysis-associated amyloidosis

Healthcare Provider Resources

Symptoms of Haemodialysis-associated amyloidosis

Causes & Risk Factors for Haemodialysis-associated amyloidosis

Diagnostic studies for Haemodialysis-associated amyloidosis

Treatment of Haemodialysis-associated amyloidosis

Continuing Medical Education (CME)

CME Programs on Haemodialysis-associated amyloidosis

International

Haemodialysis-associated amyloidosis en Espanol

Haemodialysis-associated amyloidosis en Francais

Business

Haemodialysis-associated amyloidosis in the Marketplace

Patents on Haemodialysis-associated amyloidosis

Experimental / Informatics

List of terms related to Haemodialysis-associated amyloidosis


Haemodialysis-associated amyloidosis is a form of amyloidosis associated with chronic renal failure.[1]

Presentation

Long term haemodialysis results in a gradual accumulation of β2 microglobulin, a serum protein, in the blood. It accumulates because it is unable to cross the dialysis filter.

Prevention

Low copper dialysis is theorized to prevent or delay onset.[2]

References

  1. Miyata T, Oda O, Inagi R; et al. (1993). "beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis". J. Clin. Invest. 92 (3): 1243–52. doi:10.1172/JCI116696. PMC 288264. PMID 8376584. Unknown parameter |month= ignored (help)
  2. "BU". Text " Amyloid Treatment & Research Program " ignored (help); Text " Doctors " ignored (help); Text " Aß2M Amyloidosis " ignored (help); Text " Clinical Features " ignored (help)

Amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Primary amyloidosis
Secondary amyloidosis
Familial amyloidosis
Wild-type (senile) amyloidosis
Cardiac amyloidosis
Beta-2 microglobulin related amyloidosis
Gelsolin related amyloidosis
Lysozyme amyloid related amyloidosis
Leucocyte cell-derived chemotaxin 2 related amyloidosis
Fibrinogen A alpha-chain associated amyloidosis

Pathophysiology

Causes

Differentiating Amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Haemodialysis-associated amyloidosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Haemodialysis-associated amyloidosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Haemodialysis-associated amyloidosis

CDC on Haemodialysis-associated amyloidosis

Haemodialysis-associated amyloidosis in the news

Blogs on Haemodialysis-associated amyloidosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Haemodialysis-associated amyloidosis

Template:Nephrology


Template:WikiDoc Sources